Rahul Agrawal

CMO & Head of R&D

Rahul Agrawal is Chief Medical Officer and Head of Research and Development at Cereno Scientific, a biotech developing epigenetic therapies for cardiovascular and pulmonary disease, including rare conditions. He is a senior executive with more than twenty years of experience across big pharma and biotech, spanning research and development, medical affairs, strategy and commercialisation, and has led or co-designed nearly thirty clinical trials involving more than two hundred thousand patients, contributing to the global launch of seven drugs. His career includes senior leadership roles as Chief Medical Officer at Cardior, Vice President and Global Medicines Leader at AstraZeneca, and Global Director of Medical Affairs and Clinical Development at Bayer HealthCare. He holds an MD from the Free University of Berlin and Cornell University, is board-certified in cardiology, internal medicine and emergency medicine, and holds an MBA from Buckinghamshire New University.